PMID: 8938204Nov 4, 1996Paper

Vulnerability to depression: a model centered on anhedonia

Journal of Affective Disorders
G Loas

Abstract

The aim of the present study is to present a model of depressive vulnerability centered on anhedonia. After a review of the literature, we suggest a specific symptomatic profile associating anhedonia, introversion, low sensation-seeking, autonomy, dysfunctional attitudes, high displeasure capacity, obsessive-compulsive features, passitivity and pessimism. This symptomatic profile could constitute a mild chronic mood disorder which, following stress, might decompensate into unipolar endogenomorphic depression. Several methods of research are suggested to test the validity of our model.

References

Dec 1, 1977·Journal of Personality Assessment·R M HirschfeldP Chodoff
Nov 1, 1978·Psychosomatic Medicine·S L BrownD R Sweeney
May 1, 1977·The British Journal of Psychiatry : the Journal of Mental Science·J Bowlby
Aug 1, 1976·Journal of Abnormal Psychology·L J ChapmanM L Raulin
Aug 1, 1991·Journal of Abnormal Psychology·L A Clark, D Watson
Jan 1, 1991·Psychiatry Research·K S KendlerA F Mirsky
Jul 1, 1990·The American Journal of Psychiatry·K A PhillipsL E Smith
Dec 1, 1990·The British Journal of Psychiatry : the Journal of Mental Science·G PerugiH S Akiskal
May 1, 1990·Journal of Abnormal Psychology·J KatsanisM Beiser
May 1, 1990·Psychological Medicine·H BerenbaumI I Gottesman
Oct 1, 1989·Archives of General Psychiatry·P E Meehl
Nov 1, 1989·The British Journal of Clinical Psychology·R P BentallP D Slade
Apr 1, 1989·Archives of General Psychiatry·R M HirschfeldW Coryell
Jul 1, 1987·International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology·A PiersonN Lesevre
Feb 1, 1971·Journal of Personality and Social Psychology·P Ekman, W V Friesen
Jan 1, 1967·Psychotherapy and Psychosomatics·S Lorand
Jul 1, 1983·Archives of General Psychiatry·H S AkiskalB I Yerevanian
Oct 1, 1984·The American Journal of Psychiatry·D C ClarkE Fawcett
Oct 1, 1983·Journal of Personality Assessment·C A Peterson, R M Knudson
Nov 1, 1983·Psychological Bulletin·J C Coyne, I H Gotlib
Jan 1, 1983·Archiv für Psychiatrie und Nervenkrankheiten·W LutzenbergerT Elbert
Jan 1, 1983·Archives of General Psychiatry·J FawcettR D Gibbons
Jun 8, 1995·Journal of Affective Disorders·S CartonR Jouvent
Sep 1, 1994·Journal of Affective Disorders·P Willner, S Healy
Sep 1, 1994·Psychophysiology·E R Fiorito, R F Simons
Sep 1, 1994·Comprehensive Psychiatry·G LoasB Samuel-Lajeunesse
May 1, 1993·Psychological Medicine·H Berenbaum, J McGrew
Jun 1, 1993·Schizophrenia Research·P FrankeC Hain
Dec 1, 1984·Journal of Personality Assessment·R H Dworkin, K Saczynski
May 1, 1946·The American Journal of Psychiatry·A MYERSON

❮ Previous
Next ❯

Citations

Feb 6, 2007·Psychopharmacology·Jessica Werth CookDennis McChargue
Oct 26, 2007·Psychopharmacology·Bonnie SpringDonald Hedeker
Jun 5, 2003·Physiology & Behavior·Angela J GrippoAlan Kim Johnson
Apr 13, 2011·Journal of Consulting and Clinical Psychology·Idan M AderkaEva Gilboa-Schechtman
Apr 13, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Thomas E SchlaepferVolker Sturm
Oct 9, 2009·Annals of General Psychiatry·Lorenzo Pelizza, Alberto Ferrari
Dec 21, 2013·Psychiatry Research·Justin ThomasMeera Mutawa
Aug 31, 2013·European Archives of Psychiatry and Clinical Neuroscience·Geoffrey B C HallGlenda M Macqueen
Sep 13, 2012·Cognitive, Affective & Behavioral Neuroscience·Gonçalo PadrãoAntoni Rodriguez-Fornells
May 31, 2002·BMC Psychiatry·Michel CabanacAdriana Fleury
Dec 25, 2007·Médecine sciences : M/S·Philippe-Olivier Harvey, Martin Lepage
Mar 28, 2008·Substance Use & Misuse·G MartinottiL Janiri
Aug 14, 2013·L'Encéphale·R GaillardP M Llorca
Nov 1, 2012·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Massimo Di Giannantonio, Giovanni Martinotti
Jun 23, 2012·Journal of Behavior Therapy and Experimental Psychiatry·Yoshihiko KunisatoShigeto Yamawaki
Mar 5, 2011·Progress in Neuro-psychopharmacology & Biological Psychiatry·Wen-hua LiuJackie K Gollan
Feb 10, 2011·Physiology & Behavior·Kristen A StedenfeldAlan F Sved
May 19, 2010·Psychiatry Research·Yulia Chentsova-Dutton, Kaitlin Hanley
Jun 2, 2009·Psychiatry Research·Sebastian BernertUNKNOWN ESEMeD / MHEDEA 2000 investigators
Oct 7, 2004·Depression and Anxiety·Carol A MathewsMurray B Stein
Feb 12, 2005·Biological Psychiatry·Diego A PizzagalliJames P O'Shea
Jun 30, 2006·Biological Psychiatry·Ryan Bogdan, Diego A Pizzagalli
Jul 21, 2006·Addictive Behaviors·Dennis E McChargue, Jessica Werth Cook
Nov 21, 2015·The Journal of Physiological Sciences : JPS·Noboru ShiotaShuji Aou
Apr 22, 2015·Journal of Personality Assessment·Adam M LeventhalDavid R Strong
Dec 18, 2012·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·O HorovitzG Richter-Levin
Jun 16, 2015·Journal of Affective Disorders·Kathryn FletcherDiego A Pizzagalli
Jun 5, 2012·Neurobiology of Disease·Ryan BogdanDiego A Pizzagalli

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
Gregor HaslerDennis S Charney
Archives of General Psychiatry
J FawcettR D Gibbons
© 2021 Meta ULC. All rights reserved